About Zengeza CRS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
5
HIV Vaccine Trials Network
1
Kheth'Impilo
1
University of Washington
1
Clinical Trials at Zengeza CRS
During the past decade, Zengeza CRS conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women
2009-08-01
2012-08-01
Completed
5,029
Bone Mineral Density Substudy - An Ancillary Study to MTN-003
2009-11-01
2013-05-01
Completed
518
Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women
2017-11-07
2024-11-30
Active, not recruiting
3,224
Evaluation of the PrePex Device for Rapid Scale-up of VMMC, Phase 3 Field Implementation Trial With HIV + Adult Males
2015-10-01
2016-05-01
Completed
430
Operations Research of the 'Real World' Effectiveness of Multi-Month Dispensing of ART for Stable Patients in CARGs in Zimbabwe
2017-07-28
2019-09-30
Unknown status
4,676
Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy
2020-01-09
2024-06-30
Active, not recruiting
859
Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant Pairs
2020-08-24
2021-11-04
Completed
394
Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19
2020-05-13
2022-04-21
Completed
759
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Zengeza CRS"
#1 collaborator was "Microbicide Trials Network" with 2 trials as a collaborator, "Ministry of Health and Child Welfare, Zimbabwe" with 2 trials as a collaborator, "Centers for Disease Control and Prevention" with 1 trials as a collaborator, "EQUIP Innovation for Health" with 1 trials as a collaborator and "Family Health International (FHI 360)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Zengeza CRS
According to Clinical.Site data, the most researched conditions in "Zengeza CRS" are
"HIV Infections" (5 trials), "COVID-19" (1 trials), "HIV Seropositivity" (1 trials), "HIV/AIDS" (1 trials) and "SARS-CoV-2" (1 trials). Many other conditions were trialed in "Zengeza CRS" in a lesser frequency.
Clinical Trials Intervention Types at Zengeza CRS
Most popular intervention types in "Zengeza CRS" are "Drug" (5 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Emtricitabine/tenofovir disoproxil fumarate" (2 trials), "Emtricitabine/tenofovir disoproxil fumarate placebo" (2 trials), "Tenofovir disoproxil fumarate" (2 trials), "Tenofovir disoproxil fumarate placebo" (2 trials) and "Truvada Tablet" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Zengeza CRS
The vast majority of trials in "Zengeza CRS" are
4 trials for "Female" genders, 3 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Zengeza CRS
Currently, there are NaN active trials in "Zengeza CRS".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Zengeza CRS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Zengeza CRS, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".